THE RATIONALE FOR DIAGNOSTIC AND TREATMENT TACTICS IN PATIENTS WITH NEUROENDOCRINE TUMORS OF THE SMALL INTESTINE
https://doi.org/10.24884/0042-4625-2018-177-4-28-37
Abstract
The OBJECTIVE of the study was to clarify the rational program of diagnosis and choice of treatment tactics for patients with neuroendocrine tumors (NET) of the small intestine, taking into account their clinical and morphological characteristics. MATERIAL AND METHODS. We studied the results of examination and treatment of 39 patients. RESULTS. CT is the main method of topical diagnosis, the sensitivity of which in the detection of NET of the small intestine is 96.4 %. Sign of the localization of NET in the small intestine is the tumor conglomerate of its mesentery, which includes diffuse-infiltrative and nodular variant of changes. The diffuse-infiltrative variant of tumor conglomerate is characterized by increased risk of complicated course of tumor process. Cytoreductive surgical treatment allows to increase the survival rate of patients with generalized NET of the small intestine in 1.7 times. CONCLUSION. Treatment of patients with NET of the small intestine should be carried out in specialized medical centers that have the ability to implement a multidisciplinary approach that can significantly increase the duration and quality of life of patients.
About the Authors
P. N. Romashchenko
Federal State Budgetary Military Educational Institution of Higher Education «Military Medical Academy named after S.M. Kirov» of the Ministry of Defence of the Russian Federation
Russian Federation
St. Petersburg.
Russian Federation
St. Petersburg.
N. A. Maistrenko
Federal State Budgetary Military Educational Institution of Higher Education «Military Medical Academy named after S.M. Kirov» of the Ministry of Defence of the Russian Federation
Russian Federation
St. Petersburg.
Russian Federation
St. Petersburg.
R. V. Orlova
Federal State Budgetary Educational Institution of Higher Education «Saint-Petersburg State University»
Russian Federation
St. Petersburg.
Russian Federation
St. Petersburg.
M. V. Lysanyuk
Federal State Budgetary Military Educational Institution of Higher Education «Military Medical Academy named after S.M. Kirov» of the Ministry of Defence of the Russian Federation
Russian Federation
St. Petersburg.
Russian Federation
St. Petersburg.
References
1. Bilimoria K. Y., Bentrem D. J., Wayne J. D. et al. Small Bowel Cancer in the United States Changes in Epidemiology, Treatment, and Survival Over the Last 20 Years // Ann. Surg. 2009. Vol. 249, № 1. Р. 63–71.
2. Fraenkel M., Kim M., Faggiano A., et al. Incidence of gastroenteropancreatic neuroendocrine tumours : a systematic review of the literature // Endocr. Relat. Cancer. 2014. Vol. 21, № 3. Р. 153–163.
3. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors : the rapid pace of no progress / I. M. Modlin, M. C. Champaneria, A. K. Chan, M. Kidd // Am. J. Gastroenterol. 2007. Vol. 102, № 7. Р. 1464–1473.
4. Niederle B., Pape U. F., Costa F. et al. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum // Neuroendocrinol. 2016. Vol. 103, № 2. Р. 125–138.
5. Sundin A., Arnold R., Baudin E. et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : Radiological, Nuclear Medicine & Hybrid Imaging // Neuroendocrinology. 2017. Vol. 105, № 3. Р. 212–244
6. Maxwell J. E., Sherman S. K., Stashek K. M. et al. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors // Surgery. 2014. Vol. 156, № 6. Р. 1359–1366.
7. Howe J. R., Cardona K., Fraker D. L. et al. The Surgical Management of Small Bowel Neuroendocrine Tumors : Consensus Guidelines of the North American Neuroendocrine Tumor Society // Pancreas. 2017. Vol. 46, № 6. Р. 715–731.
8. Lesurtel M., Nagorney D. M., Mazzaferro V. et al. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations // HPB (Oxford). 2015. Vol. 17, № 1. Р. 17–22.
9. Guo J., Zhang Q., Bi X. et al. Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases // Oncotarget. 2017. Vol. 8, № 10. Р. 17396–17405.
10. Lee A., Chan D. L., Wong M. H. et al. Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors // Neuroendocrinology. 2017. Vol. 104, № 3. Р. 209–222.
11. de Baere T., Deschamps F, Tselikas L. et al. GEP-NETS update : Interventional radiology : role in the treatment of liver metastases from GEP-NETs // Eur. J. Endocrinol. 2015. Vol. 172, № 4. Р. 151–166.
12. Partelli S., Bartsch D. K., Capdevila J. et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours // Neuroendocrinology. 2017. Vol. 105, № 3. Р. 255–265.
13. Tochetto S., Yaghmai V. CT enterography : concept, technique, and interpretation // Radiol. Clin. North. Am. 2009. Vol. 47, № 1. Р. 117–132.
14. Dariushnia S. R., Gill A. E., Martin L. G. et al. Quality improvement guidelines for diagnostic arteriography // J. Vasc. Interv. Radiol. 2014. Vol. 25, № 12. Р. 1873–1881.
15. Midgut neuroendocrine tumors : imaging assessment for surgical resection / L. R. Woodbridge, B. M. Murtagh, D. F. Yu, K. L. Planche // Radiographics. 2014. Vol. 34, № 2. Р. 413–426.
16. Klimstra D. S. Pathology reporting of neuroendocrine tumors : essential elements for accurate diagnosis, classification, and staging // Semin Oncol. 2013. Vol. 40, № 1. Р. 23–36.
17. Oberg K., Krenning E., Sundin A. et al. A Delphic consensus assessment : imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management // Endocr. Connect. 2016. Vol. 5, № 5. Р. 174–187.
18. Kamaoui I., De-Luca V., Ficarelli S. et al. Value of CT enteroclysis in suspected small-bowel carcinoid tumors // Am. J. Roentgenol. 2010. Vol. 194, № 3. Р. 629–633.
19. Masselli G., Casciani E., Polettini E. et al. Magnetic resonance imaging of small bowel neoplasms // Cancer Imaging. 2013. Vol. 21, № 13. Р. 92–99.
20. Fata C. R., Gonzalez R. S., Liu E. et al. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis // Am. J. Surg. Pathol. 2017. Vol. 41, № 1. Р. 128–133.
21. Bellutti M., Fry L. C., Schmitt J. et al. Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy // Dig. Dis. Sci. 2009. Vol. 54, № 5. Р. 1050–1058.
22. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours / A. Frilling, G. Smith, A. K. Clift, J. Martin // Dig. Liver Dis. 2014. Vol. 46, № 11. Р. 1038–1042.
23. Wang Y. Z., Chauhan A., Rau J. et al. Neuroendocrine tumors (NETs) of unknown primary : is early surgical exploration and aggressive debulking justifiable? // Chin. Clin. Oncol. 2016. Vol. 5, № 1. Р. 4.
24. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver / Z. Yang, D. S. Klimstra, R. H. Hruban, L. H. Tang // Am. J. Surg. Pathol. 2017. Vol. 41, № 7. Р. 915–922.
25. Vozmozhnosti lecheniya bol’nykh generalizovannymi nejroehndokrinnymi opuholyami / N. A. Majstrenko, P. N. Romashchenko, R. V. Orlova, M. V. Lysanyuk // Onkologiya: Zhurnal im. P. A. Gercena. 2018. № 2. Р. 22–27.
26. Prognozirovanie iskhodov lecheniya gastroehnteropankreaticheskikh nejroehndokrinnyh opuholej / P. N. Romashchenko, N. A. Majstrenko, R. V. Orlova, M. V. Lysanyuk // Medizinskii аkademitheskii zhurnal. 2017. Vol. 17, № 1. Р. 54–66.
27. Citterio D., Pusceddu S., Facciorusso A. et al. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver // Eur. J. Surg. Oncol. 2017. Vol. 43, № 2. Р. 380–387.
28. Mantzoros I., Savvala N. A., Ioannidis O. et al. Midgut neuroendocrine tumor presenting with acute intestinal ischemia // World J. Gastroenterol. 2017. Vol. 23, № 45. Р. 8090–8096.
29. Lepage C., Ciccolallo L., De Angelis R. et al. European disparities in malignant digestive endocrine tumours survival // Int. J. Cancer. 2010. Vol. 126, № 12. Р. 2928–2934.
30. Neuroendocrine gastro-entero-pancreatic tumors : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up / K. Öberg, U. Knigge, D. Kwekkeboom, A. Perren // Ann. Oncol. 2012. Vol. 23, № 7. P. 124–130.
Review
For citations:
Romashchenko P.N., Maistrenko N.A., Orlova R.V., Lysanyuk M.V. THE RATIONALE FOR DIAGNOSTIC AND TREATMENT TACTICS IN PATIENTS WITH NEUROENDOCRINE TUMORS OF THE SMALL INTESTINE. Grekov's Bulletin of Surgery. 2018;177(4):28-37. (In Russ.) https://doi.org/10.24884/0042-4625-2018-177-4-28-37
Views:
928
Email this article 